2024-11-04 - Analysis Report
## Teladoc Health Inc. (TDOC) Stock Analysis

**1. Performance Comparison and Alpha/Beta Analysis:**

* **Teladoc Health Inc. (TDOC)** is a telehealth company that provides virtual care services.
* The cumulative return of TDOC is **52.46%**, significantly lower than the S&P 500 (VOO) which has returned **130.3%**.
* The **current underperformance** compared to the S&P 500 is **-77.84%**, placing TDOC in the **1.21st percentile** relative to its historical performance range. 
* **Alpha/Beta analysis:** 
    * TDOC has exhibited **significant volatility** with high positive Alpha in some years (2017, 2019, 2020), indicating strong outperformance, but also negative Alpha in other years (2015, 2016, 2021, 2022, 2023, 2024), indicating underperformance.
    * The **Beta** fluctuates considerably, suggesting that TDOC's price movement is not always tightly correlated to the overall market.

**2. Recent Price Movement:**

* Closing price: **$9.21**
* 5-day moving average: **$9.03**
* 20-day moving average: **$9.11**
* 60-day moving average: **$8.25**

**3. Technical Indicators and Expected Return:**

* **RSI (52.67):** TDOC is currently in the **neutral zone** with a slightly bullish bias, suggesting neither overbought nor oversold conditions.
* **PPO (-0.6):** The negative PPO value indicates that the **momentum is slightly bearish** at the current time.
* **Delta_Previous_Relative_Divergence (+0.31):**  The positive delta suggests a **short-term upward trend** in the relative strength of TDOC compared to the S&P 500.
* **Expected Return (0.0%):** Based on the current data, the **long-term expected return** is **estimated to be zero** compared to the S&P 500. This suggests that investors should anticipate a similar level of return as the broader market.

**4. Recent Earnings and Outlook:**

* **Earnings Trend:** TDOC has experienced a consistent **decline in earnings per share (EPS)** over the past few quarters, with a notable decline in the latest quarter.
* **Revenue Trend:** Revenue has remained relatively stable over the past few quarters, with only slight fluctuations.
* **Latest Earnings:** The most recent earnings report (2024-10-31) showed an EPS of **-$0.19**, which **missed analyst expectations** by a significant margin. 
* **Future Outlook:** While revenue has remained relatively stable, the declining EPS raises concerns about the company's profitability and growth potential. Investors will closely monitor the next earnings report and management guidance to assess the company's future prospects.

**5. Financial Analysis:**

* **Revenue and Profitability:** Teladoc's revenue has remained steady but its profit margins have been declining since 2023, indicating a potential issue with profitability.
* **Capital and Profitability:** The ROE remains negative, which is concerning, and indicates the company is not generating sufficient profits from its shareholders' equity.

**6. News and Recent Issues:**

* **Recent Earnings Announcement:** The recent earnings announcement (2024-10-31) revealed a significant miss on EPS expectations, raising concerns about the company's profitability and future outlook.
* **Analyst Opinions and Performance Highlights:**  Analysts have expressed mixed opinions on TDOC's performance. Some analysts have raised concerns about the company's slowing growth and increasing competition in the telehealth industry. However, other analysts remain optimistic about the long-term prospects of telehealth and believe TDOC is well-positioned to benefit from continued industry growth.

**7. Overall Analysis:**

Teladoc Health Inc. (TDOC) is currently facing challenges in terms of profitability and growth. While the company has demonstrated significant volatility and outperformance in the past, recent earnings reports and financial data suggest a potential shift in its trajectory. The negative ROE, declining profit margins, and significant EPS miss raise concerns about the company's long-term potential. While the recent price movement shows some signs of short-term upward trend, the long-term expected return compared to the S&P 500 is estimated to be zero. 

Investors should closely monitor the company's future earnings reports, management guidance, and industry trends to assess the potential risks and opportunities associated with investing in TDOC.

**Please note:** This analysis is based on the information provided and should not be considered financial advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. 
